WHO ICTRP trial
The impact of Insulin Degludec and Liraglutide Injection on clinical remission…
ChiCTR2500101696 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500101696 |
|---|---|
| Public title | The impact of Insulin Degludec and Liraglutide Injection on clinical remission in patients with early - stage type 2 diabetes |
| Scientific title | The impact of Insulin Degludec and Liraglutide Injection on clinical remission in patients with early - stage type 2 diabetes |
| Primary sponsor | The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Type 2 diabetes |
| Interventions | Test group:On the basis of diet and exercise therapy, insulin pump intensive therapy was used to adjust the hypoglycemic regimen after discharge as degu insulin and liraglutide injection ± oral medicine.;Control group:On the basis of diet… |
| Registration date | Apr 28, 2025 |
| Target size | Test group:300;Control group:300 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: